AI-Powered Prediction Engines Provide Early Warnings for R&D, Clinical Trials, and Portfolio Risks.

Empower your teams with the power of accurate data-driven-decision-making with effortless transition from Business Intelligence to Artificial Intelligence.

Is your competitive intelligence team spending more time researching, and less in predicting R&D threats and opportunities? Give them the power of AI and slash their research time by 90% (check out case study below)! Our robust AI-powered Early Warning System (EWS) can filter and sort unwanted noise from your databases, surfacing the most pertinent information for your queries and into a collaborative platform to inform strategic decisions. Result- you can now predict competitive events accurately and act more decisively on medicine investments.

A Portfolio EWS provides probabilistic visibility into your portfolio events composition, empowering your portfolio leaders to mitigate portfolio risks and maximize value. Be it communicating early insights for capacity planning, better forecasting commercial scenario probabilities, or monitoring the effects of competitive and regulatory events on portfolio, this solution can take your basic analytics to predictive analytics with comprehensive visuals to enable data-driven- decision-making.

EWS is trained to analyze your vast clinical trials data and provide insights into future risks, and uncertainties. Once deployed, it can analyze complex data set trends to provide alerts and early warnings on trial recruitment performance and insights to identify potential risks to key study delivery milestones. The solution is flexible to be customized to your business needs.

Pharma & Lifesciences
domain expertise
in R&D

Expertise in training
Machine Learning
algorithms with life
sciences data

Experience delivering
solutions for global
pharma companies

Premium partnership with
Dataiku – a leading data
science platform for AI